AAN 2017: Optimizing the Quality of Life in Patients with Parkinson’s Disease

http://academiccme.com/wp-content/uploads/2017/06/iStock-610655566-wpcf_400x400.jpg

Course Information

Therapautic Area: Neurology
Format(s): Post Conference Review and Analysis
Credit(s): 1.0 AMA PRA Category 1 Credit(s)™
Activity Dates: June 7, 2017 - June 6, 2018

 

Program Overview

This CME activity will include data presented at the 69th Annual American Academy of Neurology Meeting held in Boston, Massachusetts from April 22 – 28, 2017. Three expert faculty, two physicians and a nurse practitioner, will review the science of Parkinson’s disease, as well as Parkinson’s disease psychosis, including motor and non-motor symptoms. An analysis of the clinical trial data of current therapeutics for the treatment of Parkinson’s disease as presented at AAN 2017 will be completed. The faculty will discuss strategies to incorporate patient education and shared-decision making into individualized treatment plans to improve the quality of life for patients with Parkinson’s disease. After participating in this program, the entire healthcare team will gain further knowledge and understanding on ways to improve outcomes for patients with Parkinson’s Disease.

Target Audience

Neurologists, Nurse Practitioners, Nurses, and other healthcare professionals who care for patients with Parkinson’s disease.

Learning Objectives

  1. Review the science of Parkinson’s disease, as well as Parkinson’s disease psychosis, including motor and non-motor symptoms.
  2. Analyze the clinical trial data of current therapeutics for the treatment of Parkinson’s disease as presented at AAN 2017.
  3. Incorporate patient education and shared-decision making into individualized treatment plans to improve the quality of life for patients with Parkinson’s disease.
  4. Recognize the important role of the healthcare team in the success of patient care.

Faculty


53524231
Daniel E. Kremens, MD
Associate Professor of Neurology
Co-Director of the Parkinson’s Disease
and Movement Disorders Division
Neurology Clerkship Director
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, Pennsylvania

 

isaacson_stuart_h_200x200 (1)__Stuart Isaacson, MD
Director, Institute for Neurodegenerative Diseases of Florida
Parkinson’s Disease and Movement Disorders Center of Boca Raton
Alzheimer’s and Memory Disorders Center of South Florida
Associate Professor of Neurology
FIU Herbert Wertheim College of Medicine
Boca Raton, Florida

GMVProfessionalPhotoGwyn M. Vernon, MSN, RN, CRNP
National Director
Edmond J. Safra Visiting Nurse Faculty Program at
the Parkinson’s Disease Foundation
Nurse Practitioner
Parkinson’s Disease and Movement Disorder Center
University of Pennsylvania
Philadelphia, Pennsylvania

Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

 

 

Faculty Relationship Identified With:
Daniel E. Kremens, MD Consultant/Advisor: Abbott; ACADIA Pharmaceuticals; Acorda Therapeutics; Adamas Pharmaceuticals, Inc.; Cynapsus Therapeutics; Impax Pharma; Kyowa Kirin Pharmaceutical Development, Inc.; Lundbeck; Merz Pharmaceuticals; Neurocrine Biosciences, Inc.; UCB Pharma, Inc.; US WorldMeds, LLC; Teva Pharmaceuticals USA
Grant/Research Support: Civitas Therapeutics; Lilly
Stuart Isaacson, MD Consultant/Advisor: AbbVie Inc.; ACADIA Pharmaceuticals, Inc.; Acorda Therapeutics; Adamas Pharmaceuticals, Inc.; Addex Therapeutics; Allergan, Inc.; Amarantus Bioscience Holdings, Inc.; Auspex Pharmaceuticals Inc; Axovant Sciences Ltd.; Biotie Therapies; Britannia Pharmaceuticals Ltd; Cynapsus Therapeutics Inc.; GE Healthcare; IMPAX Laboratories, Inc.; Ipsen; Kyowa Hakko Co., Ltd.; Lundbeck, Inc.; Medtronic, Inc.; National Parkinson Foundation; Neurocrine Biosciences, Inc.; NeuroDerm; Orexo; Pfizer Inc; Roche; Sunovion Pharmaceuticals Inc; Teva Neuroscience, Inc.; UCB Pharma, Inc.; US WorldMeds, LLC; XenoPort, Inc.
Speakers Bureau: AbbVie Inc.; ACADIA Pharmaceuticals, Inc.; Allergan, Inc.; American Parkinson Disease Association; Britannia Pharmaceuticals Ltd;Cynapsus Therapeutics Inc.; GE Healthcare; GlaxoSmithKline; IMPAX Laboratories, Inc.; Ipsen; Lundbeck, Inc.; Neurocrine Biosciences, Inc.; National Parkinson Foundation; Teva Neuroscience, Inc.; UCB Pharma, Inc.; US WorldMeds, LLC; XenoPort, Inc.
Grant/Research Support: AbbVie Inc.; ACADIA Pharmaceuticals, Inc.; Acorda Therapeutics; Adamas Pharmaceuticals, Inc.; Addex Therapeutics; Allergan, Inc.; Amarantus Bioscience Holdings, Inc.; Auspex Pharmaceuticals Inc; Avid Radiopharmaceuticals, Inc.; Axovant Sciences Ltd.; AZTherapies, Inc.; Biogen; Biotie Therapies;Cynapsus Therapeutics Inc.; Eisai Inc.; Eli Lilly and Company; Enterin; GE Healthcare;  IMPAX Laboratories, Inc.; IntecPharma; Ipsen; Kyowa Hakko Co., Ltd.; Lundbeck, Inc.; Merz Pharmaceuticals; The Michael J. Fox Foundation; Neurocrine Biosciences, Inc.; NeuroDerm; National Institute of Neurological Disorders and Stroke; Orexo; Parkinson Study Group; Pfizer Inc; Pharma Two B; Prothena; Roche; Sanofi; Shire;Sunovion Pharmaceuticals Inc; Teva Neuroscience, Inc.; UCB Pharma, Inc.; US WorldMeds, LLC; XenoPort, Inc.
Gwyn M. Vernon, MSN, RN, CRNP Consultant/Advisor: Acorda Therapeutics Inc.; Practicing Clinicians ExchangeGrant/Research Support: Impax Laboratories, Inc.

 

Planners, Managers, Reviewers

Timothy Hayes, MD, PhD; Emma Gilmartin; and Chelsey Benedek hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

AcademicCME designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Financial Support

This activity has been supported by an independent educational grant from Lundbeck.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Lundbeck do not recommend the use of any agent outside of the labeled indications.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Physicians who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME Certificate.
  6. All other participants who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.

CME Inquiries/Special Needs

For all CME inquiries or special needs, please contact admin@academiccme.com.
BUTTON

 


Provided by AcademicCME.

unnamed